$114.14
-1.49-1.29%
Últ. Act.: Sep 30, 7:57 PM
$115.68
0.05130.04%
Insmed (INSM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Insmed (INSM) publicó su última previsión de agosto 6, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $1.7B - $1.87B para el período.
En comparación con la previsión anterior, Insmed elevado redujo su previsión de ingresos desde un rango anterior de $1.45B - $1.47B.
Insmed ha emitido 16 actualizaciones de orientación entre el mayo 4, 2023 y el agosto 6, 2026. During this period, the company raised its outlook 8 times, reflecting management's growing confidence in business performance.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.74 | $-0.98 | $-1.13 | $-1.35 |
| Actual | $-0.06 | $-0.76 | $-1.54 | $-1.75 |
| Surprise | +91.9% | +22.4% | -36.3% | -29.6% |
| Revenue | ||||
| Estimate | $389.3M | $302.3M | $263.9M | $115.2M |
| Actual | $425.5M | $306.0M | $263.8M | $142.3M |
| Surprise | +9.31% | +1.23% | -0.03% | +23.6% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.36 | $-0.31 | $-0.25 | $0.03 |
| Revenue | ||||
| Consensus | $500.5M | $566.4M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.06 | $-0.74 | 91.9 % |
| Q1 | May 7, 2026 | $-0.76 | $-0.98 | 22.4 % |
| Q4 | Feb 19, 2026 | $-1.54 | $-1.13 | -36.3 % |
| Q3 | Oct 30, 2025 | $-1.75 | $-1.35 | -29.6 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $425.49M | $389.26M | 9.31 % |
| Q1 | May 7, 2026 | $305.96M | $302.26M | 1.23 % |
| Q4 | Feb 19, 2026 | $263.84M | $263.93M | -0.03 % |
| Q3 | Oct 30, 2025 | $142.34M | $115.15M | 23.6 % |